Table 4 Odds ratio of NAFLD incidence in normal uric acid group and hyperuricemia group

Age

1.009 (1.005–1.012)

< 0.001

1.008 (1.004–1.012)

< 0.001

BMI

1.117 (1.102–1.132)

< 0.001

1.108 (1.088–1.128)

< 0.001

SBP

1.002 (1.000–1.005)

0.103

0.996 (0.992–1.000)

0.047

DBP

1.014 (1.010–1.018)

< 0.001

1.021 (1.015–1.026)

< 0.001

WC

1.009 (1.103–1.114)

< 0.001

1.100 (1.092–1.108)

< 0.001

FBG

1.086 (1.044–1.130)

< 0.001

1.173 (1.103–1.248)

< 0.001

HbA1c

1.285 (1.206–1.370)

< 0.001

1.231 (1.125–1.348)

< 0.001

TG

1.602 (1.528–1.681)

< 0.001

1.376 (1.304–1.454)

< 0.001

TC

0.703 (0.639–0.734)

< 0.001

0.734 (0.647–0.833)

< 0.001

Hdl-c

0.483 (0.413–0.564)

< 0.001

0.490 (0.396–0.607)

< 0.001

Ldl-c

1.825 (1.643–2.027)

< 0.001

1.660 (1.443–1.910)

< 0.001

ALT

1.033 (1.030–1.037)

< 0.001

1.040 (1.036–1.044)

< 0.001

AST

0.966 (0.960–0.971)

< 0.001

0.975 (0.968–0.982)

< 0.001

TSH

1.004 (0.986–1.022)

0.659

0.983 (0.960–1.007)

0.158

FT3

0.926 (0.875–0.978)

< 0.001

0.927 (0.856–1.000)

0.056

FT4

0.950 (0.927–0.973)

< 0.001

0.945 (0.912–0.977)

< 0.001